Jones Financial Companies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.1K | Buy |
745
+138
| +23% | +$7.61K | ﹤0.01% | 2301 |
|
|
2025
Q1 | $43.4K | Buy |
607
+242
| +66% | +$17.3K | ﹤0.01% | 2122 |
|
|
2024
Q4 | $24K | Buy |
365
+260
| +248% | +$17.1K | ﹤0.01% | 2174 |
|
|
2024
Q3 | $7.41K | Buy |
105
+20
| +24% | +$1.41K | ﹤0.01% | 2325 |
|
|
2024
Q2 | $7K | Buy |
+85
| New | +$7K | ﹤0.01% | 1865 |
|
|
2024
Q1 | – | Sell |
-450
| Closed | -$43.4K | – | 1372 |
|
|
2023
Q4 | $43.4K | Buy |
+450
| New | +$43.4K | ﹤0.01% | 494 |
|
|
2021
Q2 | – | Sell |
-17
| Closed | -$1K | – | 642 |
|
|
2021
Q1 | $1K | Sell |
17
-70
| -80% | -$4.12K | ﹤0.01% | 763 |
|
|
2020
Q4 | $8K | Buy |
+87
| New | +$8K | ﹤0.01% | 450 |
|
|
2013
Q3 | – | Sell |
-115
| Closed | -$6K | – | 724 |
|
|
2013
Q2 | $6K | Buy |
+115
| New | +$6K | ﹤0.01% | 661 |
|